Nona Scientific Welcomes Industry Veteran Robb Chapin as Chair of Newly Formed Advisory Board

Chapin will work closely with CEO Mac McKellar to oversee the company’s strategic initiatives, leveraging his extensive experience in healthcare and retirement home investments based in Florida.

OCALA, FL / ACCESSWIRE / September 11, 2024 / Nona Scientific, a leading provider of cutting-edge diagnostic solutions to assisted living facilities, physician practices and healthcare facilities, is proud to announce the appointment of Robb Chapin as Chairman of its newly formed Advisory Board, effective September 5, 2024. This significant step formally establishes the Nona Scientific Advisory Board, which will play a key role in guiding the strategic direction and growth of the company.

Nona Scientific has built a reputation as one of the nation’s leading clinical laboratories, offering a broad range of diagnostic services designed to meet the evolving needs of physicians and the senior community. The company’s commitment to innovation and excellence is reflected in its state-of-the-art laboratory capabilities that deliver accurate and timely diagnostic information critical to effective medical decision-making.

Robb Chapin, co-founder of Channel Marker Advisors and recently retired CEO of Bridge Investment Group, brings over 30 years of corporate leadership experience to Nona Scientific. His distinguished career includes leadership roles such as CEO and Co-Chief Investment Officer of Bridge Seniors Housing Fund Manager LLC, where he successfully led strategic growth initiatives in the healthcare real estate sector.

“I am honored to assume the role of Chairman of the Nona Scientific Advisory Board,” said Robb Chapin. “The formation of this board marks a new chapter for Nona Scientific, and I am excited to contribute to its strategic growth. Nona Scientific’s commitment to advancing healthcare through innovative diagnostics is something I am deeply passionate about, and I look forward to working with Mac and the entire team to further expand the company’s impact on the healthcare community.”

The formation of the Advisory Board and the appointment of Mr. Chapin underscore Nona Scientific’s commitment to strategic growth and excellence and are key milestones for Nona Scientific as the company continues to expand and expand its reach in the healthcare community. Mr. Chapin’s extensive experience in the senior and healthcare sectors, including his leadership at Servant Healthcare Investments, LLC, positions him as a key asset in leading the company’s expansion efforts. This move also sends a clear signal to competitors that Nona Scientific has the capacity to achieve significant growth and maintain its leadership position in diagnostics.

“We are thrilled not only to welcome Robb Chapin as our Advisory Board Chairman, but also to officially launch the Advisory Board itself,” said Mac McKellar, CEO of Nona Scientific. “This board will play a critical role in shaping the future of Nona Scientific, and Robb’s strategic vision and experience make him the ideal leader for this endeavor. His leadership will help us continue our mission of providing exceptional diagnostic services that support healthcare providers in delivering excellent patient care.”

Contact Information

Mac Mckellar
CEO of Nona Scientific
[email protected]
352-260-4700

SOURCE: Scientific None

The original press release can be read at newswire.com.